Cancer center support grant

项目摘要 俄亥俄州立大学综合癌症中心-亚瑟·G·詹姆斯癌症医院和 理查德·J·索洛夫研究所(OSUCCC-James)自1976年以来一直是NCI指定的CCC。这个 OSUCCC的使命仍然是通过持续的基础、翻译、 人口和临床研究。 消除整个癌症护理过程中的差异，将不同的人群纳入 研究对于开发预防、诊断和治疗癌症的新方法至关重要。OSUCCC是 致力于为所有在我们设施中寻求治疗的个人提供整个癌症过程中最好的治疗， 这包括参与研究。确保OSUCC内人口数量的一种方法-詹姆斯 集水区得到最好的照顾是通过让各个社区参与并提供癌症 提高认识，特别是对参与审判的重要性的认识。 我们将把拟议的补充方案重点放在在我们的城市实施临床试验计划上 服务不足的非裔美国人、低收入高加索人、西班牙裔/拉丁裔、亚洲人和难民(索马里和尼泊尔语) 社区，并在所有这些人口以及在我们的阿巴拉契亚和 农村县。 为实现本非补编的目标，并在以前旨在 消除健康差距，OSUCCC将利用两名社区健康教育者(总计1.2 FTE)在 与研究人员和NCI赞助的主要学术、社区和区域合作伙伴合作，以 通过实现以下目标，提高NCI有效接触服务不足和少数族裔社区的能力 具体目标： 目标1：提高对临床试验和生物制品研究的认识和知识，并促进 参与哥伦布市城市社区种族/民族多元化社区的临床试验 通过实施临床试验(CT)和生物制品研究参与倡议；以及 目标2：提高对可能导致癌症的HPV类型的认识和知识，并感染HPV 通过实施人类疫苗在我们集水区的各种服务不足的人群中接种疫苗 乳头瘤病毒(HPV)推广和疫苗接种倡议。

Project Summary The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has been a NCI designated CCC since 1976. The OSUCCC mission remains to reduce cancer morbidity and mortality through continued basic, translational, population and clinical research. Eliminating disparities across the continuum of cancer care, with the inclusion of a diverse population in research, is vital to the development of new modalities to prevent, diagnose, and treat cancer. The OSUCCC is committed to providing the best care across the cancer continuum to all individuals who seek care at our facilities, which includes participation in research. One way to ensure that the population within the OSUCC-James catchment area receives best possible care is through engaging the various communities and providing cancer awareness, especially an understanding of the importance of trial participation. We will focus the proposed supplement on implementing a Clinical Trials Initiative within our urban underserved African American, low income Caucasian, Hispanic/Latino, Asian, and refugee (Somali and Nepali) communities, and an HPV Vaccination Initiative in all of these populations, as well as in our Appalachian and rural counties. To accomplish the goals of this NON supplement and build upon previous outreach efforts aimed at eliminating health disparities, OSUCCC will utilize two community health educators (1.2 total FTE) to work in partnership with researchers and key NCI-sponsored academic, and community, and regional partners to enhance NCI’s ability to effectively reach underserved and minority communities through achieving the following specific aims: Aim 1: Increase awareness and knowledge about clinical trials and biospecimen research and facilitate participation in clinical trials among racially/ethnically diverse communities in urban Columbus communities through implementation of Clinical Trial (CT) & Biospecimen Studies Participation Initiative; and Aim 2: Increase awareness and knowledge of the HPV types that can lead to cancer and uptake of the HPV vaccine in the various underserved populations in our catchment area through implementation of the Human Papillomavirus (HPV) Outreach and Vaccination initiative.